Previous Article | Next Article 
Journal of Virology, September 2001, p. 8063-8073, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8063-8073.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Susceptibility of Rat-Derived Cells to Replication
by Human Immunodeficiency Virus Type 1
Oliver T.
Keppler,1
Wesley
Yonemoto,1
Frank J.
Welte,1
Kathryn S.
Patton,1,
Demetris
Iacovides,2
Robert E.
Atchison,1,
Tuan
Ngo,1
David L.
Hirschberg,3,§
Roberto F.
Speck,1,
and
Mark A.
Goldsmith1,4,*
Gladstone Institute of Virology and
Immunology1 and Departments of
Physiology2 and
Medicine,4 School of Medicine,
University of California San Francisco, San Francisco, California
94141-9100, and Department of Neurology and Neurological
Sciences, Stanford University, Stanford, California
943053
Received 5 April 2001/Accepted 2 June 2001
Progress in developing a small animal model of human
immunodeficiency virus type 1 (HIV-1) disease would greatly facilitate studies of transmission, pathogenesis, host immune responses, and
antiviral strategies. In this study, we have explored the potential of
rats as a susceptible host. In a single replication cycle, rat cell
lines Rat2 and Nb2 produced infectious virus at levels 10- to 60-fold
lower than those produced by human cells. Rat-derived cells supported
substantial levels of early HIV-1 gene expression, which was further
enhanced by overexpression of human cyclin T1. Rat cells displayed
quantitative, qualitative, and cell-type-specific limitations in the
late phase of the HIV-1 replication cycle including relative expression
levels of HIV-1 Gag proteins, intracellular Gag processing, and viral
egress. Nb2 cells were rendered permissive to HIV-1 R5 viruses by
coexpression of human CD4 and CCR5, indicating that the major
restriction on HIV-1 replication was at the level of cellular entry. We
also found that primary rat lymphocytes, macrophages, and microglia expressed considerable levels of early HIV-1 gene products following infection with pseudotyped HIV-1. Importantly, primary rat macrophages and microglia, but not lymphocytes, also expressed substantial levels
of HIV-1 p24 CA and produced infectious virions. Collectively, these
results identify the rat as a promising candidate for a transgenic
small animal model of HIV-1 infection and highlight pertinent
cell-type-specific restrictions that are features of this species.
*
Corresponding author. Mailing address: Gladstone
Institute of Virology and Immunology, P.O. Box 419100, San Francisco,
CA 94141. Phone: (415) 695-3775. Fax: (415) 695-1364. E-mail:
mgoldsmith{at}gladstone.ucsf.edu.

Present address: Dynavax Technologies Corporation, Berkeley, CA
94710.

Present address: Rigel Pharmaceuticals, Inc., South San
Francisco, CA
94080.
§
Present address: Agilent Technologies, Palo Alto, CA
94304.

Present address: University Hospital Zürich, CH-8091
Zürich,
Switzerland.
Journal of Virology, September 2001, p. 8063-8073, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8063-8073.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Goffinet, C., Allespach, I., Oberbremer, L., Golden, P. L., Foster, S. A., Johns, B. A., Weatherhead, J. G., Novick, S. J., Chiswell, K. E., Garvey, E. P., Keppler, O. T.
(2009). Pharmacovirological Impact of an Integrase Inhibitor on Human Immunodeficiency Virus Type 1 cDNA Species In Vivo. J. Virol.
83: 7706-7717
[Abstract]
[Full Text]
-
Peng, Y., Lin, F.-c., Verardi, P. H., Jones, L. A., Yilma, T. D.
(2009). Lower Levels of Gamma Interferon Expressed by a Pseudotyped Single-Cycle Simian Immunodeficiency Virus Enhance Immunogenicity in Rats. J. Virol.
83: 1592-1601
[Abstract]
[Full Text]
-
Sun, J., Zheng, J. H., Zhao, M., Lee, S., Goldstein, H.
(2008). Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides. J. Virol.
82: 5562-5572
[Abstract]
[Full Text]
-
Goffinet, C., Allespach, I., Keppler, O. T.
(2007). HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc. Natl. Acad. Sci. USA
104: 1015-1020
[Abstract]
[Full Text]
-
Tsurutani, N., Yasuda, J., Yamamoto, N., Choi, B.-I., Kadoki, M., Iwakura, Y.
(2007). Nuclear Import of the Preintegration Complex Is Blocked upon Infection by Human Immunodeficiency Virus Type 1 in Mouse Cells. J. Virol.
81: 677-688
[Abstract]
[Full Text]
-
Venzke, S., Michel, N., Allespach, I., Fackler, O. T., Keppler, O. T.
(2006). Expression of Nef Downregulates CXCR4, the Major Coreceptor of Human Immunodeficiency Virus, from the Surfaces of Target Cells and Thereby Enhances Resistance to Superinfection. J. Virol.
80: 11141-11152
[Abstract]
[Full Text]
-
Michel, N., Ganter, K., Venzke, S., Bitzegeio, J., Fackler, O. T., Keppler, O. T.
(2006). The Nef Protein of Human Immunodeficiency Virus Is a Broad-Spectrum Modulator of Chemokine Receptor Cell Surface Levels That Acts Independently of Classical Motifs for Receptor Endocytosis and G{alpha}i Signaling. Mol. Biol. Cell
17: 3578-3590
[Abstract]
[Full Text]
-
Keppler, O. T., Tibroni, N., Venzke, S., Rauch, S., Fackler, O. T.
(2006). Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J. Leukoc. Biol.
79: 616-627
[Abstract]
[Full Text]
-
Sun, J., Soos, T., KewalRamani, V. N., Osiecki, K., Zheng, J. H., Falkin, L., Santambrogio, L., Littman, D. R., Goldstein, H.
(2006). CD4-Specific Transgenic Expression of Human Cyclin T1 Markedly Increases Human Immunodeficiency Virus Type 1 (HIV-1) Production by CD4+ T Lymphocytes and Myeloid Cells in Mice Transgenic for a Provirus Encoding a Monocyte-Tropic HIV-1 Isolate. J. Virol.
80: 1850-1862
[Abstract]
[Full Text]
-
Potash, M. J., Chao, W., Bentsman, G., Paris, N., Saini, M., Nitkiewicz, J., Belem, P., Sharer, L., Brooks, A. I., Volsky, D. J.
(2005). A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc. Natl. Acad. Sci. USA
102: 3760-3765
[Abstract]
[Full Text]
-
Keppler, O. T., Allespach, I., Schuller, L., Fenard, D., Greene, W. C., Fackler, O. T.
(2005). Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef. J. Virol.
79: 1655-1665
[Abstract]
[Full Text]
-
Marozsan, A. J., Fraundorf, E., Abraha, A., Baird, H., Moore, D., Troyer, R., Nankja, I., Arts, E. J.
(2004). Relationships between Infectious Titer, Capsid Protein Levels, and Reverse Transcriptase Activities of Diverse Human Immunodeficiency Virus Type 1 Isolates. J. Virol.
78: 11130-11141
[Abstract]
[Full Text]
-
Hatziioannou, T., Cowan, S., Bieniasz, P. D.
(2004). Capsid-Dependent and -Independent Postentry Restriction of Primate Lentivirus Tropism in Rodent Cells. J. Virol.
78: 1006-1011
[Abstract]
[Full Text]
-
Koito, A., Kameyama, Y., Cheng-Mayer, C., Matsushita, S.
(2003). Susceptibility of Mink (Mustera vision)-Derived Cells to Replication by Human Immunodeficiency Virus Type 1. J. Virol.
77: 5109-5117
[Abstract]
[Full Text]
-
Yedavalli, V. S. R. K., Benkirane, M., Jeang, K.-T.
(2003). Tat and Trans-activation-responsive (TAR) RNA-independent Induction of HIV-1 Long Terminal Repeat by Human and Murine Cyclin T1 Requires Sp1. J. Biol. Chem.
278: 6404-6410
[Abstract]
[Full Text]
-
Twu, C., Liu, N. Q., Popik, W., Bukrinsky, M., Sayre, J., Roberts, J., Rania, S., Bramhandam, V., Roos, K. P., MacLellan, W. R., Fiala, M.
(2002). Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc. Natl. Acad. Sci. USA
99: 14386-14391
[Abstract]
[Full Text]
-
Keppler, O. T., Welte, F. J., Ngo, T. A., Chin, P. S., Patton, K. S., Tsou, C.-L., Abbey, N. W., Sharkey, M. E., Grant, R. M., You, Y., Scarborough, J. D., Ellmeier, W., Littman, D. R., Stevenson, M., Charo, I. F., Herndier, B. G., Speck, R. F., Goldsmith, M. A.
(2002). Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. JEM
195: 719-736
[Abstract]
[Full Text]